Stay updated on RTX-240 Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the RTX-240 Combo with Pembrolizumab in Clinical Trial page
- Check3 days agoChange DetectedA new revision label 'Revision: v3.6.5' appears in the history list, replacing 'Revision: v3.6.4'. This reflects a software release update for the page's UI, with no changes to the study data shown.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision entry for v3.6.4 has been added to the page's history, replacing the previous v3.6.3 entry. This reflects an internal update to the record history metadata rather than changes to the visible study information.SummaryDifference0.1%

- Check46 days agoChange DetectedA new study record revision v3.6.3 was added to the history and the older revision v3.6.0 was removed, reflecting an update to the record's documentation.SummaryDifference0.1%

- Check60 days agoChange DetectedRecruitment for RTX-240 is no longer open, indicating a closed enrollment status in the study history. The record now shows Revision: v3.6.0 (replacing the prior v3.5.5).SummaryDifference0.5%

- Check67 days agoChange DetectedA new release note 'Revision: v3.5.5' was added to the page history. The previous release note 'Revision: v3.5.4' was removed.SummaryDifference0.1%

- Check89 days agoChange DetectedA new revision entry v3.5.4 is added to the Record History, replacing the previous v3.5.3 entry.SummaryDifference0.1%

Stay in the know with updates to RTX-240 Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.